Eli Lilly and Company vs Merck & Co Inc

Eli Lilly and Company and Merck & Co Inc both operate in the Healthcare sector, so comparing them is a choice between direct rivals: both are exposed to the same market forces, and the question is which handles them better.

This page puts both sets of numbers side by side. It does not declare a winner — VAQO is not an investment adviser — it arranges what you need to compare, instead of leaving you to open two pages and hold figures in your head.

Healthcare · Drug Manufacturers
$1,123.98
+0.01%
Day range: $1,119.01 – $1,138.70
Volume: 2.0M
Healthcare · Drug Manufacturers
$147.59
-0.59%
Day range: $147.19 – $149.60
Volume: 8.5M

What the numbers show

In the latest session Eli Lilly and Company (LLY) led with 0.01% against -0.59% for Merck & Co Inc (MRK) — a gap of 0.59 percentage points.

LLY vs MRK — frequently asked questions

How much do Eli Lilly and Company and Merck & Co Inc cost today?

Eli Lilly and Company (LLY) trades at $1,123.98 (+0.01%) and Merck & Co Inc (MRK) at $147.59 (-0.59%) in the latest session.

What is the difference between Eli Lilly and Company and Merck & Co Inc?

Eli Lilly and Company (LLY) and Merck & Co Inc (MRK) both operate in the Healthcare sector, so they are direct rivals exposed to the same market forces. The difference between them is performance and valuation, not what they do.

LLY or MRK — which is better?

VAQO makes no recommendations and is not an investment adviser. What it provides is both sets of numbers side by side — price, daily move, volatility and risk scoring from a model whose accuracy is published openly — so the decision rests on a comparison rather than a feeling.

This is not financial advice.

← All comparisons

Last updated: 2026-09-10